Proqr Therapeutics NVPRQR
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 47 institutions reported holding Proqr Therapeutics NV (PRQR) in their 13F filings, down 1 from Q2 2024. 4 opened new positions and 5 sold out. The largest holders were Privium Fund Management B.V. ($10.3M), Adage Capital Partners Gp, L.L.C. ($6.6M) and EcoR1 Capital, LLC ($3.3M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Proqr Therapeutics NV
- CUSIP
- N71542109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $41K |
| Exits | 5 | $40K |
All 13F filers, Q2 2024 → Q3 2024: 827,347 shares bought and 674,140 shares sold, net +153,207 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 47 holders
| Privium Fund Management B.V. | 2.55% | Add +0.9% | 5,632,388 | $10.3M |
| Adage Capital Partners Gp, L.L.C. | 0.01% | No change | 3,625,467 | $6.6M |
| EcoR1 Capital, LLC | 0.11% | Reduce -10.1% | 1,835,991 | $3.3M |
| M28 Capital Management LP | 2.04% | No change | 1,019,498 | $1.9M |
| DAFNA Capital Management LLC | 0.39% | No change | 905,582 | $1.6M |
| Ghost Tree Capital, LLC | 0.55% | Reduce -1.4% | 887,700 | $1.6M |
| Macquarie Group Ltd. | 0.00% | No change | 620,000 | $1.1M |
| Ikarian Capital, LLC | 0.27% | No change | 483,583 | $880K |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +565.9% | 412,190 | $750K |
| Monaco Asset Management SAM | 0.25% | Add +4.9% | 327,892 | $597K |
| Morgan Stanley | 0.00% | Add +252.1% | 274,450 | $499K |
| Franklin Street Advisors Inc. | 0.02% | No change | 150,000 | $273K |
| Millennium Management | 0.00% | Reduce -3.0% | 143,929 | $262K |
| Deutsche Bank AG | 0.00% | Reduce -71.8% | 108,762 | $198K |
| Boothbay Fund Management, LLC | 0.01% | No change | 106,703 | $194K |
| Acadian Asset Management LLC | 0.00% | Add +2273.7% | 93,358 | $165K |
| Two Sigma Advisers, LP | 0.00% | Reduce -33.5% | 87,500 | $159K |
| Citadel Advisors | 0.00% | Add +373.6% | 86,977 | $158K |
| Bank of America Corp. | 0.00% | No change | 73,163 | $133K |
| Squarepoint Ops LLC | 0.00% | Reduce -15.6% | 71,491 | $130K |
| Two Sigma Investments, LP | 0.00% | Reduce -9.3% | 62,520 | $114K |
| BNP Paribas Financial Markets | 0.00% | Add +14.2% | 58,801 | $107K |
| OneDigital Investment Advisors LLC | 0.00% | Add +37.0% | 57,550 | $105K |
| Geode Capital Management, LLC | 0.00% | No change | 46,671 | $85K |
| Susquehanna International Group, LLP | 0.00% | Reduce -56.1% | 42,223 | $77K |
| RFG Advisory, LLC | 0.00% | Add +31.3% | 42,000 | $76K |
| Bank of Montreal | 0.00% | No change | 30,000 | $55K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | No change | 21,429 | $39K |
| Mariner, LLC | 0.00% | No change | 18,334 | $33K |
| Northern Trust Corp. | 0.00% | Reduce -1.1% | 15,750 | $29K |
| Prudential Financial Inc. | 0.00% | New | 13,200 | $24K |
| Atom Investors LP | 0.00% | No change | 13,107 | $24K |
| EP Wealth Advisors, LLC | 0.00% | No change | 11,500 | $21K |
| Csenge Advisory Group | 0.00% | No change | 10,000 | $19K |
| Kestra Advisory Services, LLC | 0.00% | No change | 10,000 | $18K |
| Truist Financial Corp. | 0.00% | No change | 10,000 | $18K |
| Wells Fargo & Company | 0.00% | Reduce -16.1% | 9,226 | $17K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 7,496 | $14K |
| Osaic Holdings, Inc. | 0.00% | Reduce -40.8% | 7,250 | $13K |
| BlackRock, Inc. | 0.00% | — | 3,945 | $7K |
| UBS Group AG | 0.00% | Reduce -89.5% | 2,900 | $5K |
| Flaharty Asset Management, LLC | 0.00% | New | 2,000 | $4K |
| PFS Partners, LLC | 0.00% | No change | 1,000 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.5% | 300 | $546 |
| TD Waterhouse Canada Inc. | 0.00% | New | 40 | $70 |
| Royal Bank of Canada | 0.00% | Reduce -81.0% | 200 | $0 |
| Lazard Asset Management LLC | 0.00% | Reduce -62.7% | 103 | $0 |
"% of holder's portfolio" is PRQR's weight in each manager's 13F, not the share of Proqr Therapeutics NV the manager owns.